ISSN (print) 1726-9806     ISSN (online) 1818-474X
No. 1 (2018), INTENSIVE CARE IN DISEASES OF NERVOUS SYSTEM
No. 1 (2018)
INTENSIVE CARE IN DISEASES OF NERVOUS SYSTEM

Perioperative management of patients with depression

Published 24.03.2018
Victoria V. Myasnikova
The Academician S.N. Fyodorov ISTC “Eye Microsurgery”, Krasnodar; Kuban State Medical University of the Ministry of Public Health of the Russian Federation, Krasnodar
https://orcid.org/0000-0003-1748-7962
A.E. Muronov
Kuban State Medical University of the Ministry of Public Health of the Russian Federation, Krasnodar
https://orcid.org/0000-0002-5156-4469
#2018-1
PDF_2018-1_16-26 (Russian)

Keywords

depression
perioperative management
antidepressants
electroconvulsive therapy

How to Cite

1.
Myasnikova V.V., Muronov A.E. Perioperative management of patients with depression. Annals of Critical Care. 2018;(1):16-26. doi:10.21320/1818-474X-2018-1-16-26
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Statistic

Abstract Views: 72
PDF_2018-1_16-26 (Russian) Downloads: 286
Statistic from 01.07.2024

Language

English Русский

Most reader

Social Networks

Abstract

One of the most common mental illnesses, occurring in more than 5 % of the adult population, is depression. In the management of patients with this concomitant pathology in the perioperative period, the anesthesiologist must take into account a number of characteristics. These may be possible difficulties in communication due to patient closure, the risk of developing a “withdrawal syndrome” of antidepressants, side effects, as well as undesirable interactions of these drugs with anesthetics. The article reviews the publications of Russian and foreign articles and manuals on the perioperative management of patients with depression. The characteristics of the main groups of modern drugs for the treatment of depression, the tactics of their withdrawal or continuation of admission before the operation, the features of anesthesia against the background of long-term intake of various groups of antidepressants are presented. The problem of such complication of therapy with these drugs, such as serotonin syndrome, its differential diagnosis is considered. The review also includes non-pharmacological treatments for depression, their complications and anesthesia in electroconvulsive therapy.
PDF_2018-1_16-26 (Russian)

References

  1. Периоперационное ведение пациентов с сопутствующими заболеваниями: руководство для врачей : в 3 т. Под ред. И.Б. Заболотских. Т. 1. 2-е изд., перераб. и доп. М.: Практическая медицина, 2016. [Perioperatsionnoe vedenie patsientov s soputstvuyushchimi zabolevaniyami. Rukovodstvo dlya vrachei: in 3 vol. Ed. I.B. Zabolotskikh. Vol. 1. 2nded. Moscow: Prakticheskaya meditsina, 2016. (In Russ)]
  2. Периоперационное ведение пациентов с сопутствующими заболеваниями: руководство для врачей : в 3 т. Под ред. И.Б. Заболотских. Т. 2. 2-е изд., перераб. и доп. М.: Практическая медицина, 2016. [Perioperatsionnoe vedenie patsientov s soputstvuyushchimi zabolevaniyami. Rukovodstvo dlya vrachei: in 3 vol. Ed. I.B. Zabolotskikh. Vol. 2. 2nded. Moscow: Prakticheskaya meditsina, 2016. (In Russ)]
  3. Анестезиология-реаниматология. Клинические рекомендации. Подред. И.Б. Заболотских, Е.М. Шифмана. М.: ГЭОТАР-Медиа, 2016. [Аnesteziologiya-reanimatologiya. Klinicheskie rekomendatsii. Pod red. I.B. Zabolotskikh, E.M. Shifmana. M.: GEOTАR-Media, 2016. (In Russ)]
  4. Kaye A.D., Liu H., Fox C., et al. Psychiatric and Behavioral Disorders. In: Anesthesia and Uncommon diseases.6thed. Ed. L.A. Fliesher. Philadelphia: Saunders Elsevier, 2012: 444–469.
  5. Levenson J.L. Psychiatric issues in surgical patients. Part I: General issues. Prim. Psychiatry. 2007: 14: 35–39.
  6. Practice Advisory for Pre-anesthesia Evaluation. A Report by the American Society of Anesthesiologists. Task Force on Pre-anesthesia Evaluation Approved by the House of Delegates Oct 17, 2001. Last amended Oct 15, 2003. ASA, Park Ridge, IL.
  7. Hemmings H.C., Hopkins P.M. Foundations of anesthesia: basic sciences for clinical practice. 2nded. Elsevier Health Sciences, 2006: 346–347.
  8. Attri J.P., Bala N., Chatrath V. Psychiatric patient and anaesthesia. Indian J. Anaesth. 2012; 56(1): 8–13. doi: 10.4103/0019-5049.93337.
  9. Kessler R.C., Berglund P., Demler O., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS–R), JAMA. 2003; 289: 3095–3105. doi: 10.1001/jama.289.23.3095
  10. Morgan G.E., Mikhail M.S., Murray M.J. Anesthesia for patients with neurologic and psychiatric diseases. In Morgan and Mikhail’s: Clinical anaesthesiology. 4thed. USA: LANGE International edition, 2008: 647–661.
  11. Ghoneim M.M., O’Hara M.W. Depression and postoperative complications: an overview. BMC Surg. 2016; 16: 5. doi: 10.1186/s12893-016-0120-y PMCID: PMC4736276.
  12. Hines R.L., Marschall K.E. Psychiatric disease/substance abuse/drug overdose. Stoeltingʼs: Anaesthesia and co-existing diseases. 7th ed. Elsevier, 2017: 611–633.
  13. Zolezzi M. Medication management during electroconvulsant therapy. Neuropsychiatr. Dis. Treat. 2016; 12: 931–939. doi: 10.2147/NDT.S100908.
  14. Howland R.H. Potential adverse effects of discontinuing psychotropic drugs. J.Psychosoc. Nurs. Ment. Health. Serv. 2010; 48: 9–12. doi: 10.3928/02793695-20100730-04.
  15. БыковЮ.В., Беккер Р.А., Резников М.К. Депрессии и резистентность: практическое руководство. М., РИОР: 2013. [Bykov Yu.V., Bekker R.A., Reznikov M.K. Depressii i rezistentnostʼ: prakticheskoye rukovodstvo. Moskva: RIOR, 2013. (In Russ)]
  16. Kocsis J.H., Friedman R.A., Markowitz J.C., et al. Maintenance therapy for chronic depression. Arch. Gen. Psychiatry 1996; 53: 769–774.
  17. Руководство по клинической анестезиологии: пер. с англ. Под ред. Б.Дж. Полларда, под общ. ред. Л.В. Колотилова, В.В. Мальцева. М.: МЕДпресс-информ, 2006 [Rukovodstvo po klinicheskoy anesteziologii. Pod red. B.Dzh.Pollarda, pod obshch. red. L.V. Kolotilova, V.V. Malʼtseva. M.: MEDpress-inform, 2006. (In Russ)]
  18. Huyse F.J., Touw D.J., Strack van Schijndel R.J., et al. Measures for patients taking psychotropic drugs who undergo elective surgery. [Article in Dutch.] Ned. Tijdschr. Geneeskd. 2007; 151(6): 353–357.
  19. Warner C.H., Bobo W., Warner C., et al. Antidepressant discontinuation syndrome. Am. Fam. Physician. 2006; 74(3): 449–456.
  20. Bérard A., Gaedigk A., Sheehy O., et al. Association between CYP2D6 Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during Pregnancy. Front. Pharmacol. 2017; 8: 402. doi: 10.3389/fphar.2017.00402.
  21. Kudoh A., Ishihara H., Matsuki A. Inhibition of the cortisol response to surgical stress in chronically depressed patients. J. Clin. Anesth. 2000; 12(5): 383–387.
  22. Takeguchi Y., Miyamoto Y., Sone T., Kato H. Severe hypotension during anesthesia in a patient on long-term antidepressant therapy. [Article in Japanese.] Masui. 2003; 52(3): 284–287.
  23. Nakamura S., Takeda K., Nishiyama T., Hanaoka K. General anesthesia for a patient with Noonanʼs syndrome and long-term antidepressant therapy. [Article in Japanese.] Masui. 2005; 54(8): 901–903.
  24. Copeland L.A., Zeber J.E., Pugh M.J., et al. Postoperative complications in the seriously mentally ill: a systematic review of the literature. Ann. Surg. 2008; 248(1): 31–38. doi: 10.1097/SLA.0b013e3181724f25.
  25. Kudoh A. Preoperative evaluation, preparation and prognosis in depressed patients. Masui. 2010; 59(9): 1116–1127.
  26. Butler S.G., Meegan M.J. Recent developments in the design of antidepressant therapies: Targeting the serotonin transporter. Curr. Med. Chem. 2008; 15:1737–1761.
  27. Glassman A.H., Roose S.P., Bigger J.T. The safety of tricyclic antidepressants in cardiac patients: risk-benefit reconsidered. JAMA. 1993; 269: 2673–2675.
  28. Desan P.H., Powsner S. Assessment and management of patients with psychiatric disorders. Crit. Care Med. 2004; 32(4 Suppl.):S166–173.
  29. Veith R.C., Raskind M.A., Caldwell J.H., et al. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease, N. Engl. J. Med. 1982; 306: 954–959.
  30. Thompson T.L., Moran M.G., Nies A.S. Psychotropic drug use in the elderly, N. Engl. J. Med. 1983; 308: 194–198.
  31. Folk J.W., Kellner C.H., Beale M.D., et al. Anesthesia for electroconvulsive therapy: a review. J. ECT. 2000; 16(2): 157–170.
  32. Veith R.C., Raskind M.A., Caldwell J.H., et al. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease, N. Engl. J. Med.1982; 306: 954–959.
  33. Smith F.A., Wittmann C.W., Stern T.A. Medical complications of psychiatric treatment. Crit. Care Clin. 2008; 24: 635–656.
  34. Takakura K., Nagaya M., Mori M., et al. Refractory hypotension during combined general and epidural anaesthesia in a patient on tricyclic antidepressants. Anaesth. Intensive Care. 2006; 34(1): 111–114.
  35. Huyse F.J., Touw D.J., Schijndel R.S., et al. Psychotropic drugs and the perioperative period: A proposal for a guideline in elective surgery. Psychosomatics. 2006; 47: 8–22.
  36. Kudoh A., Takase H., Takazawa T. Chronic treatment with antidepressants decreases interoperative core hypothermia. Anesth. Analg. 2003; 97: 275–279.
  37. Ding Z., White P.F. Anesthesia for electroconvulsive therapy. Anesth. Analg. 2002; 94: 1351–1364.
  38. Pacher P., Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr. Pharm. Des. 2004; 10(20): 2463–2475.
  39. Choudhury M., Hote M.P., Verma Y. Serotonin syndrome in a postoperative patient. J. Anaesth. Clin. Pharmacol. 2011; 27: 233–235.
  40. Brent J. Critical care toxicology: diagnosis and management of the critically poisoned patient. Elsevier Health Sciences, 2005: 485–488.
  41. Chand P.K., Kalyani G.S., Murthy P. Venlafaxine associated hypomania in unipolar depression. Can. J. Psychiatry. 2004; 49: 496.
  42. Van der Klauw M.M., Wilson J.H., Stricker B.H. Drug-associated agranulocytosis: 20 years of reporting in the Netherlands (1974–1994). Am. J. Hematol. 1998; 57: 206–211.
  43. Deiner S., Frost E.A. Electroconvulsive therapy and anesthesia. Int. Anesthesiol. Clin. 2009; 47: 81–92. doi: 10.1097/AIA.0b013e3181939b37.
  44. Walder B., Seeck M., Tramer M.R. Propofol versus methohexital for electroconvulsive therapy. A meta-analysis. J. Neurosurg. Anesthesiol. 2001; 13: 93–98.
  45. Wagner K.J., Möllenberg O., Rentrop M., et al. Guide to anaesthetic selection for electroconvulsive therapy. CNS Drugs. 2005; 19(9): 745–758.
  46. Recart A., Rawal S., White P.F., et al. The effect of remifentanil on seizure duration and acute hemodynamic responses to electroconvulsive therapy. Anesth. Analg. 2003; 96(4): 1047–1050.
  47. Takekita Y., Suwa T., Sunada N., et al. Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials. Eur. Arch. Psychiatry Clin. Neurosci. 2016; 266(8): 703–717. doi: 10.1007/s00406-016-0670-0.
  48. Naguib M., Koorn R. Interactions between psychotropics, anaesthetics and electroconvulsive therapy: implications for drug choice and patient management. CNS Drugs. 2002; 16(4): 229–247.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2018 ANNALS OF CRITICAL CARE